Bovine herpesvirus VP22 induces apoptosis in neuroblastoma cells by upregulating the expression ratio of Bax to Bcl-2

Human Gene Therapy

Volumn 16, Issue 1, 2005, Pages 101-108

  Qiu, Zhaohua ^a   Zhu, Jun ^a   Harms, Jerome S ^a   Friedrichsen, Jennifer ^a   Splitter, Gary A ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b AHABS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HERPESVIRUS VECTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN VP22;

ANIMAL CELL; APOPTOSIS; ARTICLE; BOVINE HERPES VIRUS; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; EQUINE HERPES VIRUS; GENE THERAPY; GENETIC TRANSFECTION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SUICIDE GENE THERAPY;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CATTLE; CELL CYCLE; HUMANS; MICE; NEUROBLASTOMA; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE DELETION; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION; VIRAL STRUCTURAL PROTEINS;

EID: 13844253349     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.101     Document Type: Article

References (35)

1. AGARWAL, N., and MEHTA, K. (1997). Possible involvement of Bcl-2 pathway in retinoid X receptor α-induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun. 230, 251-253.
2. AGGARWAL, S., and GUPTA, S. (1998). Increased apoptosis of T cell subsets in aging humans: Altered expression of Fas (CD95), Fas ligand, Bcl-2. and Bax. J. Immunol. 160, 1627-1637.
3. BENNETT, R.P., DALBY, B., and GUY, P.M. (2002). Protein delivery using VP22. Nat. Biotechnol. 20, 20.
4. BREWIS, N., PHELAN, A., WEBB, J., DREW, J., ELLIOTT, G., and O'HARE, P. (2000). Evaluation of VP22 spread in tissue culture. J. Virol. 74, 1051-1056.
5. DARGAN, D. (1986). The structure and assembly of herpes viruses. In Viral Structure. J.R. Harris and R.W. Home, eds. (Academic Press, New York) pp. 359-437.
6. ELLIOTT, G., and O'HARE, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
7. ELLIOTT, G., and O'HARE, P. (1999a). Intercellular trafficking of VP22-GFP fusion proteins. Gene Ther. 6, 149-151.
8. ELLIOTT, G., and O'HARE, P. (1999b). Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J. Virol. 73, 4110-4119.
9. FALNES, P.O., WESCHE, J., and OLSNES, S. (2001). Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment. Biochemistry 40, 4349-4358.
10. FANG, B., XU, B., KOCH, P., and ROTH, J.A. (1998). Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther. 5, 1420-1424.
11. GREENE, L.A., SHAIN, W., CHALAZONITIS, A., BREAKFIELD, X., MINNA, J., COON, H.G., and NIRENBERG, M. (1975). Neuronal properties of hybrid neuroblastoma X sympathetic ganglion cells. Proc. Natl. Acad. Sci. U.S.A. 72, 4923-4927.
12. HEINE, J.W., HONESS, R.W., CASSAI, E., and ROIZMAN, B. (1974). Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J. Virol. 14, 640-651.
13. KORSMEYER, S.J. (1999). BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59(7 Suppl.), 1693s-1700s.
14. KORSMEYER, S.J., SHUTTER, J.R., VEIS, D.J., MERRY, D.E., and OLTVAI, Z.N. (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4, 327-332.
15. LESLIE, J., RIXON, F.J., and MCLAUCHLAN, J. (1996). Overexpression of the herpes simplex virus type 1 tegument protein VP22 increases its incorporation into virus particles. Virology 220, 60-68.
16. LIANG, X., CHOW, B., and BABIUK, L.A. (1997). Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. Vaccine 15, 1057-1064.
17. LIU, C.S., KONG, B., XIA, H.H., ELLEM, K.A., and WEI, M.Q. (2001). VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. J. Gene Med. 3, 145-152.
18. LUNDBERG, M., and JOHANSSON, M. (2001). Is VP22 nuclear homing an artifact? [Letter]. Nat. Biotechnol. 19, 713-714.
19. NORMAND, N., VAN LEEUWEN, H., and O'HARE, P. (2001). Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J. Biol. Chem. 276, 15042-15050.
20. OLTVAI, Z.N., MILLIMAN, C.L., and KORSMEYER, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
21. PHELAN, A., ELLIOTT, G., and O'HARE, P. (1998). Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16, 440-443.
22. POMERANZ, L.E., and BLAHO, J.A. (1999). Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J. Virol. 73, 6769-6781.
23. PORTER, A.G., and JANICKE, R.U. (1999). Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99-104.
24. QIU, Z., HARMS, J.S., ZHU, J., and SPLITTER, G.A. (2004). Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared with herpes simplex virus VP22. J. Virol. 78, 4224-4233.
25. REN, X., HARMS, J.S., and SPLITTER, G.A. (2001). Bovine herpesvirus 1 tegument protein VP22 interacts with histones, and the carboxyl terminus of VP22 is required for nuclear localization. J. Virol. 75, 8251-8258.
26. ROY, I., HOLLE, L., SONG, W., HOLLE, E., WAGNER, T., and YU, X. (2002). Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res. 22, 3185-3189.
27. SPEAR, P.G., and ROIZMAN, B. (1972). Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J. Virol. 9, 143-159.
28. STEVEN, A.C., and SPEAR, P.G. (1997). Herpesvirus capsid assembly and envelopment. In Structural Biology of Viruses. W. Chiu, R.M. Burnett, and R.L. Carcea, eds. (Oxford University Press, New York) pp. 312-351.
29. THORNBERRY, N.A., and LAZEBNIK, Y. (1998). Caspases: Enemies within. Science 281, 1312-1316.
30. WILLS, K.N., ATENCIO, I.A., AVANZINI, J.B., NEUTEBOOM, S., PHELAN, A., PHILOPENA, J., SUTJIPTO, S., VAILLANCOURT, M.T., WEN, S.F., RALSTON, R.O., and JOHNSON, D.E. (2001). Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J. Virol. 75, 8733-8741.
31. WYBRANIETZ, W.A., GROSS, C.D., PHELAN, A., O'HARE, P., SPIEGEL, M., GRAEPLER, F., BITZER, M., STAHLER, P., GREGOR, M., and LAUER, U.M. (2001). Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther. 8, 1654-1664.
32. ZAVAGLIA, D., FAVROT, M.C., EYMIN, B., TENAUD, C., and COLL, J.L. (2003). Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered p27-VP22 fusion protein. Gene Ther. 10, 314-325.
33. ZENDER, L., KUHNEL, F., KOCK, R., MANNS, M., and KUBICKA, S. (2002a). VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo. Cancer Gene Ther. 9, 489-496.
34. ZENDER, L., KOCK, R., ECKHARD, M., FRERICKS, B., GOSLING, T., GEBHARDT, T., DROBEK, S., GALANSKI, M., KUHNEL, F., MANNS, M., and KUBICKA, S. (2002b). Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterology 123, 608-618.
35. ZOU, H., LI, Y., LIU, X., and WANG, X. (1999). An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556.